Structural determinants for the action of grayanotoxin in D1 S4-S5 and D4 S4-S5 intracellular linkers of sodium channel alpha-subunits.
We located a novel binding site for grayanotoxin on the cytoplasmic linkers of voltage-dependent cardiac (rH1) or skeletal-muscle (mu 1) Na(+) channel isoforms (segments S4-S5 in domains D1 and D4), using the alanine scanning substitution method. GTX-modification of Na(+) channels, transiently expressed in HEK 293 cells, was evaluated under whole-cell voltage clamp, from the ratio of maximum chord conductance for modified and unmodified Na(+) channels. In mu 1, mutations K237A, L243A, S246A, K248A, K249A, L250A, S251A, or T1463A, caused a moderate, but statistically significant decrease in this ratio. On making corresponding mutations in rH1, only L244A dramatically reduced the ratio. Because in mu 1, the serine at position 251 is the only heterologous residue with respect to rH1 (Ala-252), we made a double mutant L243A&S251A to match the sequence of mu 1 and rH1 in S4-S5 linkers of both domains. This double mutation resulted in a significant decrease in the ratio, to the same extent as L244A substitution in rH1 did, indicating that the site at Leu-244 in rH1 or at Leu-243 in mu 1 is a novel one, exhibiting a synergistic effect of grayanotoxin.
Maejima
Hiroshi
H
Institute of Health Sciences, School of Medicine, Hiroshima University, Hiroshima, Kasumi 1-2-3, Hiroshima 734-8551, Japan.
Kinoshita
Eiji
E
Yuki
Tsunetsugu
T
Yakehiro
Masuhide
M
Seyama
Issei
I
Yamaoka
Kaoru
K
D000409:Alanine / Q000235:genetics; D000818:Animals; D002478:Cells, Cultured; D004224:Diterpenes / Q000737:chemistry / Q000494:pharmacology*; D015640:Ion Channel Gating; D007700:Kinetics; D016296:Mutagenesis; D011487:Protein Conformation; D051381:Rats; D015222:Sodium Channels / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics; D014118:Toxins, Biological / Q000737:chemistry / Q000494:pharmacology*
D004224:Diterpenes; D015222:Sodium Channels; D014118:Toxins, Biological; D000409:Alanine